Anti-neutrophil Cytoplasmic Antibodies in New-onset Systemic Lupus Erythematosus and Lupus Nephritis (original) (raw)

Abstract

This study aims to investigate the role of Antineutrophil cytoplasmic antibodies (ANCA) in patients with new-onset systemic lupus erythematosus (SLE). Sixty SLE patients, 28 of whom had lupus nephritis (LN), and 60 normal controls were enrolled; Serum ANCA was measured by enzyme linked immunosorbent assay (ELISA). The clinical and laboratory parameters of the patients were also recorded. Results show that twenty SLE patients were seropositive for ANCA, which was significantly higher than in normal controls. LN patients had significantly higher positive rate of ANCA than patients without nephritis. Compared with ANCA-negative patients, the ANCA-positive patients had significantly higher incidence of nerves system disorder, myocarditis, renal involvement and serositis. The positive rate of γ-globulin, anti-dsDNA and anti-Sm antibodies were significantly higher in ANCA-positive patients. Elevated IgG and ESR, decreased serum C3/C4 appeared more often in ANCA-positive patients. In addition, serum ANCA level correlated positively with disease activity. Taken together, ANCA might be used as a potential complementary parameter to differentiate LN from SLE without nephritis. In addition, ANCA may serve as a useful marker of the disease activity of SLE.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

The alternative text for this image may have been generated using AI.

Fig. 2

The alternative text for this image may have been generated using AI.

Similar content being viewed by others

References

  1. Davies, D. J., J. E. Moran, J. F. Niall, and G. B. Ryan. 1982. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br. Med. J. 285(6342):606.
    Article CAS Google Scholar
  2. Savige, J. A., D. J. Davies, and P. A. Gatenby. 1994. Anti-neutrophil cytoplasmic antibodies (ANCA): their detection and significance: report from workshops. Pathology. 26(2):186–193.
    Article PubMed CAS Google Scholar
  3. Ardiles, L. G., G. Valderrama, P. Moya, and S. A. Mezzano. 1997. Incidence and studies on antigenic specificities of antineutrophil-cytoplasmic antibodies (ANCA) in poststreptococcal glomerulonephritis. Clin. Nephrol. 47(1):1–15.
    PubMed CAS Google Scholar
  4. Jennette, J. C., R. J. Falk, K. Andrassy, P. A. Bacon, J. Churg, W. L. Gross, E. C. Hagen, G. S. Hoffman, G. G. Hunder, C. G. Kallenberg et al. 1994. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 37(2):187–192.
    Article PubMed CAS Google Scholar
  5. Drenkard, C., A. R. Villa, E. Reyes, M. Abello, and D. Alarcón-Segovia. 1997. Vasculitis in systemic lupus erythematosus. Lupus 6(3):235–242.
    Article PubMed CAS Google Scholar
  6. Pradhan, V. D., S. S. Badakere, L. S. Bichile, and A. F. Almeida. 2004. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. J. Assoc. Phys. India 52:533–537.
    Google Scholar
  7. Tang, Z., Y. Wu, Q. Wang, C. Zeng, X. Yao, W. Hu, H. Chen, Z. Liu, and L. Li. 2003. Clinical spectrum of diffuse crescentic glomerulonephritis in Chinese patients. Chin. Med. J. (Engl) 116(11):1737–1740.
    Google Scholar
  8. Fauzi, A. R., N. C. Kong, M. K. Chua, V. Jeyabalan, M. N. Idris, and R. Azizah. 2004. Antibodies in systemic lupus antineutrophil cytoplasmic erythematosus: prevalence, disease activity correlations and organ system associations. Med. J. Malaysia 59(3):372–377.
    PubMed CAS Google Scholar
  9. Molnár, K., L. Kovács, M. Kiss, S. Husz, A. Dobozy, and G. Pokorny. 2002. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus. Clin. Exp. Dermatol. 27(1):59–61.
    Article PubMed Google Scholar
  10. Lee, S. S., J. W. Lawton, C. E. Chan, C. S. Li, T. H. Kwan, and K. F. Chau. 1992. Antilactoferrin antibody in systemic lupus erythematosus. Br. J. Rheumatol. 31(10):669–673.
    Article PubMed CAS Google Scholar
  11. Ecklund, S. R., G. S. Saluta, C. A. Agudelo, and E. J. Pisko. 1992. Antineutrophil cytoplasmic antibodies: clinical characteristics of 10 patients with the perinuclear pattern of immunofluorescence on ANCA testing. South Med. J. 85(2):132–138.
    PubMed CAS Google Scholar
  12. Kuster, S., S. Apenberg, K. Andrassy, and E. Ritz. 1992. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Contrib. Nephrol. 99:94–98.
    PubMed CAS Google Scholar
  13. Pauzner, R., M. Urowitz, D. Gladman, and J. Gough. 1994. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. J. Rheumatol. 21(9):1670–1673.
    PubMed CAS Google Scholar
  14. Chin, H. J., C. Ahn, C. S. Lim, H. K. Chung, J. G. Lee, Y. W. Song, H. S. Lee, J. S. Han, S. Kim, and J. S. Lee. 2000. Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis. Am. J. Nephrol. 20(1):57–63.
    Article PubMed CAS Google Scholar
  15. Tan, E. M., A. S. Cohen, J. F. Fries, A. T. Masi, D. J. McShane, N. F. Rothfield, J. G. Schaller, N. Talal, and R. J. Winchester. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25(11):1271–1277.
    Article PubMed CAS Google Scholar
  16. Bombardier, C., D. D. Gladman, M. B. Urowitz, D. Caron, and C. H. Chang. 1992. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 35(6):630–640.
    Article PubMed CAS Google Scholar
  17. Tamiya, H., K. Tani, J. Miyata, K. Sato, T. Urata, B. Lkhagvaa, S. Otsuka, S. Shigekiyo, and S. Sone. 2006. Defensins- and cathepsin G-ANCA in systemic lupus erythematosus. Rheumatol. Int. 27(2):147–152.
    Article PubMed CAS Google Scholar

Download references

Acknowledgments

This work was supported by grants from the National Natural Science Foundation of China (30571608, 30771848) and the Specialized Research Fund for the Doctoral Program of Higher Education of China (20070366002). We are deeply indebted to the people who have participated in this study; we also thank Dr Bo-Ke Zhang, the First Affiliated Hospital of Anhui Medical University and Dr Guo-Sheng Wang, Anhui Provincial Hospital, for assistance in case identification; Their cooperation was invaluable to this research.

Author information

Authors and Affiliations

  1. Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Hefei, Anhui, 230032, People’s Republic of China
    Hai-Feng Pan, Xue-Hui Fang, Wen-Xian Li, Xue-Fei Zhao & Dong-Qing Ye
  2. Department of Rheumatology, Anhui Provincial Hospital, Hefei, China
    Xiang-Pei Li
  3. Department of Rheumatology, First Affiliated Hospital, Anhui Medical University, Hefei, China
    Jian-Hua Xu
  4. Department of Pharmacology, Anhui Medical University, Hefei, China
    Guo-Cui Wu

Authors

  1. Hai-Feng Pan
  2. Xue-Hui Fang
  3. Guo-Cui Wu
  4. Wen-Xian Li
  5. Xue-Fei Zhao
  6. Xiang-Pei Li
  7. Jian-Hua Xu
  8. Dong-Qing Ye

Corresponding author

Correspondence toDong-Qing Ye.

Additional information

Hai-Feng Pan and Xue-Hui Fang contributed equally to this work

Rights and permissions

About this article

Cite this article

Pan, HF., Fang, XH., Wu, GC. et al. Anti-neutrophil Cytoplasmic Antibodies in New-onset Systemic Lupus Erythematosus and Lupus Nephritis.Inflammation 31, 260–265 (2008). https://doi.org/10.1007/s10753-008-9073-3

Download citation

KEY WORDS

Profiles

  1. Hai-Feng Pan View author profile
  2. Guo-Cui Wu View author profile
  3. Dong-Qing Ye View author profile